TASS, January 17: The COVID-19 vaccine developed by the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences may enter civilian circulation in March 2021, the Center’s Deputy Director General for Project Activities and Innovation Konstantin Chernov told Vesti Nedeli news program on Rossiya-1 TV channel.
"Our coronavirus vaccine can enter civilian circulation probably around March," he said.
According to Chernov, more than 50 different proteins have already been found in the coronavirus genome. "When we provide the body with the full spectrum of everything that is there, we expect that the protection will be more complex," he explained.
On August 11, Russia was the first in the world to register a coronavirus vaccine Sputnik V developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Healthcare Ministry. Later, the Novosibirsk-based Vector State Research Center of Virology and Biotechnology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing registered another domestic vaccine. According to Anna Popova, Russia’s chief sanitary doctor, who heads the federal service, a third vaccine created by the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences may be registered soon.
